R
Regan Fulton
Researcher at Kaiser Permanente
Publications - 20
Citations - 927
Regan Fulton is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 10, co-authored 18 publications receiving 724 citations. Previous affiliations of Regan Fulton include Stanford University.
Papers
More filters
Journal ArticleDOI
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
Marilyn L. Kwan,Lawrence H. Kushi,Erin Weltzien,Benjamin Maring,Susan E. Kutner,Regan Fulton,Marion M. Lee,Christine B. Ambrosone,Bette J. Caan +8 more
TL;DR: These observations suggest that investigators should consider tumor heterogeneity in associations with traditional breast cancer risk factors, and important modifiable lifestyle factors that may be related to the development of a specific tumor subtype, but not all subtypes, include obesity, breastfeeding, and alcohol consumption.
Journal ArticleDOI
Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center.
Patrick L. Fitzgibbons,Linda A Bradley,Lisa A. Fatheree,Randa Alsabeh,Regan Fulton,Jeff Goldsmith,Thomas Haas,Rouzan G. Karabakhtsian,Patti A. Loykasek,Monna Marolt,Steven S. Shen,Anthony T. Smith,Paul E. Swanson +12 more
TL;DR: Recommendations were derived from strength of evidence, open comment feedback, and expert panel consensus to help pathology laboratories comply with validation and revalidation requirements for immunohistochemical assays.
Journal ArticleDOI
Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.
Maria S. Tretiakova,Regan Fulton,Masha Kocherginsky,Thomas J. Long,Cigdem Ussakli,Tatjana Antic,Allen M. Gown +6 more
TL;DR: The overall results are highly concordant suggesting diagnostic equivalence of tested assays, and a significant subset of 56/235 urothelial carcinomas stained positive for PD-L1 with high concordance between all four antibodies and RNA ISH assay.
Journal ArticleDOI
Markers of metastatic carcinoma of breast origin.
TL;DR: This review summarizes the three major breast‐associated markers that can be of assistance in evaluating metastatic carcinomas for which a breast primary diagnosis is entertained, which include gross cystic disease fluid protein‐15, mammaglobin, and GATA3.
Journal ArticleDOI
Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
Myrto Moutafi,Charles J. Robbins,Vesal Yaghoobi,Aileen I. Fernandez,Sandra Martinez-Morilla,Vasiliki Xirou,Yalai Bai,Yang Song,Patricia Gaule,Joseph S. Krueger,Kenneth Bloom,Salisha Hill,Daniel C. Liebler,Regan Fulton,David L. Rimm +14 more
TL;DR: In this article , the authors used the AQUA method of quantitative immunofluorescence to test a range of antibody concentrations to maximize the sensitivity within the lower range of HER2 expression.